{"data":{"id":"us/38-cfr-4.115b","jurisdiction":"us","citation":"38 CFR 4.115b","heading":"b Ratings of the genitourinary system—diagnoses.","body":"Rating\nNote: When evaluating any claim involving loss or loss of use of one or more creative organs, refer to § 3.350 of this chapter to determine whether the veteran may be entitled to special monthly compensation. Footnotes in the schedule indicate conditions which potentially establish entitlement to special monthly compensation; however, there are other conditions in this section which under certain circumstances also establish entitlement to special monthly compensation.\n7500 Kidney, removal of one:\nMinimum evaluation 30\nOr rate as renal dysfunction if there is nephritis, infection, or pathology of the other.\n7501 Kidney, abscess of:\nRate as urinary tract infection\n7502 Nephritis, chronic:\nRate as renal dysfunction.\n7504 Pyelonephritis, chronic:\nRate as renal dysfunction or urinary tract infection, whichever is predominant.\n7505 Kidney, tuberculosis of:\nRate in accordance with §§ 4.88b or 4.89, whichever is appropriate.\n7507 Nephrosclerosis, arteriolar:\nRate according to predominant symptoms as renal dysfunction, hypertension or heart disease. If rated under the cardiovascular schedule, however, the percentage rating which would otherwise be assigned will be elevated to the next higher evaluation.\n7508 Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis:\nRate as hydronephrosis, except for recurrent stone formation requiring invasive or non-invasive procedures more than two times/year 30\n7509 Hydronephrosis:\nSevere; Rate as renal dysfunction.\nFrequent attacks of colic with infection (pyonephrosis), kidney function impaired 30\nFrequent attacks of colic, requiring catheter drainage 20\nOnly an occasional attack of colic, not infected and not requiring catheter drainage 10\n7511 Ureter, stricture of:\nRate as hydronephrosis, except for recurrent stone formation requiring one or more of the following:\n1. diet therapy\n2. drug therapy\n3. invasive or non-invasive procedures more than two times/year 30\n7512 Cystitis, chronic, includes interstitial and all etiologies, infectious and non-infectious:\nRate as voiding dysfunction.\n7515 Bladder, calculus in, with symptoms interfering with function:\nRate as voiding dysfunction\n7516 Bladder, fistula of:\nRate as voiding dysfunction or urinary tract infection, whichever is predominant.\nPostoperative, suprapubic cystotomy 100\n7517 Bladder, injury of:\nRate as voiding dysfunction.\n7518 Urethra, stricture of:\nRate as voiding dysfunction.\n7519 Urethra, fistula of:\nRate as voiding dysfunction.\nMultiple urethroperineal fistulae 100\n7520 Penis, removal of half or more 1 30\n7521 Penis, removal of glans 1 20\n7522 Erectile dysfunction, with or without penile deformity 1 0\nNote: For the purpose of VA disability evaluation, a disease or traumatic injury of the penis resulting in scarring or deformity shall be rated under diagnostic code 7522.\n7523 Testis, atrophy complete:\nBoth—20 1\nOne—0 1\n7524 Testis, removal:\nBoth 1 30\nOne 1 0\nNote: In cases of the removal of one testis as the result of a service-incurred injury or disease, other than an undescended or congenitally undeveloped testis, with the absence or nonfunctioning of the other testis unrelated to service, an evaluation of 30 percent will be assigned for the service-connected testicular loss. Testis, undescended, or congenitally undeveloped is not a ratable disability.\n7525 Prostatitis, urethritis, epididymitis, orchitis (unilateral or bilateral), chronic only:\nRate as urinary tract infection.\nFor tubercular infections: Rate in accordance with §§ 4.88b or 4.89, whichever is appropriate.\n7527 Prostate gland injuries, infections, hypertrophy, postoperative residuals, bladder outlet obstruction:\nRate as voiding dysfunction or urinary tract infection, whichever is predominant.\n7528 Malignant neoplasms of the genitourinary system 100\nNote—Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.\n7529 Benign neoplasms of the genitourinary system:\nRate as voiding dysfunction or renal dysfunction, whichever is predominant.\n7530 Chronic renal disease requiring regular dialysis:\nRate as renal dysfunction.\n7531 Kidney transplant:\nFollowing transplant surgery 100\nThereafter: Rate on residuals as renal dysfunction, minimum rating 30\nNote—The 100 percent evaluation shall be assigned as of the date of hospital admission for transplant surgery and shall continue with a mandatory VA examination one year following hospital discharge. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter.\n7532 Renal tubular disorders (such as renal glycosurias, aminoacidurias, renal tubular acidosis, Fanconi's syndrome, Bartter's syndrome, related disorders of Henle's loop and proximal or distal nephron function, etc.):\nMinimum rating for symptomatic condition 20\nOr rate as renal dysfunction.\n7533 Cystic diseases of the kidneys:\nRate as renal dysfunction.\nNote: Cystic diseases of the kidneys include, but are not limited to, polycystic disease, uremic medullary cystic disease, medullary sponge kidney, and similar conditions such as Alport's syndrome, cystinosis, primary oxalosis, and Fabry's disease.\n7534 Atherosclerotic renal disease (renal artery stenosis, atheroembolic renal disease, or large vessel disease, unspecified):\nRate as renal dysfunction.\n7535 Toxic nephropathy (antibotics, radiocontrast agents, nonsteroidal anti-inflammatory agents, heavy metals, and similar agents):\nRate as renal dysfunction.\n7536 Glomerulonephritis:\nRate as renal dysfunction.\n7537 Interstitial nephritis, including gouty nephropathy, disorders of calcium metabolism:\nRate as renal dysfunction.\n7538 Papillary necrosis:\nRate as renal dysfunction.\n7539 Renal amyloid disease:\nRate as renal dysfunction.\nNote: This diagnostic code pertains to renal involvement secondary to all glomerulonephritis conditions, all vasculitis conditions and their derivatives, and other renal conditions caused by systemic diseases, such as Lupus erythematosus, systemic lupus erythematosus nephritis, Henoch-Schonlein syndrome, scleroderma, hemolytic uremic syndrome, polyarthritis, Wegener's granulomatosis, Goodpasture's syndrome, and sickle cell disease.\n7540 Disseminated intravascular coagulation with renal cortical necrosis:\nRate as renal dysfunction.\n7541 Renal involvement in diabetes mellitus type I or II:\nRate as renal dysfunction.\n7542 Neurogenic bladder:\nRate as voiding dysfunction or urinary tract infection, whichever is predominant.\n7543 Varicocele/Hydrocele 1 0\n7544 Renal disease caused by viral infection such as human immunodeficiency virus (HIV), Hepatitis B, and Hepatitis C:\nRate as renal dysfunction.\n7545 Bladder, diverticulum of:\nRate as voiding dysfunction or urinary tract infection, whichever is predominant.\n1 Review for entitlement to special monthly compensation under § 3.350 of this chapter.","path":["Title 38—Pensions, Bonuses, and Veterans' Relief","CHAPTER I—DEPARTMENT OF VETERANS AFFAIRS","PART 4—SCHEDULE FOR RATING DISABILITIES","Subpart B—Disability Ratings"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-38.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:25:50Z","sha256":"6d475143a8fbcb7c34509c83758b096f5beef7bc5feb727aa5c8c46b1ac0f133","source_id":"us-cfr","stale":true,"prev":"us/38-cfr-4.115a","next":"us/38-cfr-4.116"},"notice":"GroundRules: Original legal text. Not legal advice."}